The potential of coagulation/flocculation process for the removal of the selected pharmaceuticals SIbuprofen, Diclofenac, Carbamazepine, Valsartan, and Ethinylestradiol was investigated. For this purpose, several composite coagulants were prepared in the laboratory from the combination of polymerized aluminium (PACl) and an inorganic additive (polysilicates, pSi) and an organic positively charged additive (p-DADMAC). By applying two synthesis methods (co-polymerization and composite polymerization) and different basicities or [OH]/[Al] ratios, several products were produced. The prepared coagulants (of PASiC, PACSi and PACL-pDADMAC type) were characterised by means of basic properties such as pH, turbidity, conductivity. Moreover, the impact of the synthesis process with the different additives and conditions on the Al species distribution was studied. The treatment efficiency was studied by using model tap water after adding 1 mg/L of each compound. Several jar-tests were conducted, and the final concentrations of IBU, CBZ, IBF, DCF and VLS were determined by HPLC-UV/DAD. It was revealed that the composite polymerization results in more efficient coagulants than the Co-polymerization method. PACSi was the best one, achieving up to 90 % removal of Ethinylestradiol 90 %, 80% both Ibuprofen and Diclofenac, while 60% Valsartan, and only 10% Carbamazepine. The basicity has a strong impact on the efficiency, with the [OH]/[Al] = 1 achieving the best results, whereas the increase of the [OH]/[Al] to 1.5 and 2 reduced the performance significantly. pH and dose were adjusted to achieve the best removal efficiency and it was 6 and 10 ppm respectively.